Therefore, we hypothesized that the elevated expression of nucleolin could regulate glucose metabolism to exert cardioprotective effects, which was expected to provide a new therapeutic target for patients with sepsis in clinical practice. This evidence concerns the gene NUCLEOLIN and Sepsis.